Research Center for Molecular Mechanisms of Aging and Age-Related Diseases, Moscow Institute of Physics and Technology, Dolgoprudny, Moscow Region, Russia.
Research Center for Molecular Mechanisms of Aging and Age-Related Diseases, Moscow Institute of Physics and Technology, Dolgoprudny, Moscow Region, Russia; Dynamic Bioimaging Lab, Advanced Optical Microscopy Centre, Biomedical Research Institute, Agoralaan C (BIOMED), Hasselt University, Diepenbeek, Belgium; Laboratory for Photochemistry and Spectroscopy, Division for Molecular Imaging and Photonics, Department of Chemistry, KU Leuven, Leuven, Belgium.
J Mol Biol. 2023 Dec 1;435(23):168310. doi: 10.1016/j.jmb.2023.168310. Epub 2023 Oct 6.
G protein-coupled receptors (GPCRs) form the largest superfamily of membrane proteins in the human genome, and represent one of the most important classes of drug targets. Their structural studies facilitate rational drug discovery. However, atomic structures of only about 20% of human GPCRs have been solved to date. Recombinant production of GPCRs for structural studies at a large scale is challenging due to their low expression levels and stability. Therefore, in this study, we explored the efficacy of the eukaryotic system LEXSY (Leishmania tarentolae) for GPCR production. We selected the human A adenosine receptor (AAR), as a model protein, expressed it in LEXSY, purified it, and compared with the same receptor produced in insect cells, which is the most popular expression system for structural studies of GPCRs. The AAR purified from both expression systems showed similar purity, stability, ligand-induced conformational changes and structural dynamics, with a remarkably higher protein yield in the case of LEXSY expression. Overall, our results suggest that LEXSY is a promising platform for large-scale production of GPCRs for structural studies.
G 蛋白偶联受体(GPCRs)是人类基因组中最大的膜蛋白超家族,也是最重要的药物靶点之一。对其结构的研究有助于合理的药物发现。然而,迄今为止,只有大约 20%的人类 GPCR 的原子结构被解析。由于其表达水平低和稳定性差,因此大规模用于结构研究的 GPCR 的重组生产具有挑战性。因此,在本研究中,我们探索了真核系统 LEXSY(莱什曼原虫)用于 GPCR 生产的效果。我们选择了人类 A 腺苷受体(AAR)作为模型蛋白,在 LEXSY 中表达它,然后对其进行纯化,并与用于 GPCR 结构研究的最流行的表达系统——昆虫细胞中表达的相同受体进行了比较。从两种表达系统中纯化的 AAR 具有相似的纯度、稳定性、配体诱导的构象变化和结构动力学,而 LEXSY 表达的情况下蛋白产量明显更高。总的来说,我们的结果表明 LEXSY 是用于结构研究的 GPCR 大规模生产的有前途的平台。